This Week in the British Journal of Cancer

In the British Journal of Cancer this week: genotype study of irinotecan in gastric cancer, anti-tumor activity from HIF-pathway inhibitor NSC-134754, and more.

Focus on the Prostate

Two new studies elucidate the genetic subtypes of prostate cancer.

This Week in BMC Cancer

In BMC Cancer this week: customized chemotherapy based on EGFR mutation status, IL-10 polymorphisms in colorectal cancer, and more.

The Importance of Acknowledgement

Three researchers discuss the heterogeneity of cancer and the implications for therapies and diagnostics.

This Week in Cancer Discovery

In Cancer Discovery this week: differential sensitivity of glioma compared to lung cancer to EGFR inhibitors, and more.

Even More Complex

A new study on breast cancer shows the importance of accurate disease classification.

This Week in the Journal of the National Cancer Institute

In the Journal of the National Cancer Institute this week: glycogen synthase kinase-3β in human osteosarcoma, staging systems for pancreatic neuroendocrine neoplasms, and more.

High Tech

A new study may unseat flow cytometry as the standard method for the detection of residual disease in leukemia patients.

This Week in Lancet Oncology

In Lancet Oncology this week: the prognostic value of a microRNA signature in nasopharyngeal carcinoma, and more.

'One More Piece in the Puzzle'

A new study finds an early biomarker for pancreatic cancer.

This Week in the British Journal of Cancer

In the British Journal of Cancer this week: effect of statins on prostate cancer, germline BRCA1 mutations and prostate cancer risk, and more.

A Light on p53

Researchers may have found a remedy for a cancer-associated mutation.

This Week in BMC Cancer

In BMC Cancer this week: image-guided radiotherapy in patients with head and neck cancer, survival rates in lung cancer patients with co-morbidities, and more.